These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3280932)

  • 21. Clinical experience with Campylobacter pylori in western Kentucky.
    Kraus JW; Morello PJ
    J Ky Med Assoc; 1989 Sep; 87(9):448-50. PubMed ID: 2794757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antibiotics for Campylobacter pylori colonization of the stomach].
    Schmidt G; Opferkuch W; Rühl G; Haase G
    Dtsch Med Wochenschr; 1989 Nov; 114(46):1812-3. PubMed ID: 2583013
    [No Abstract]   [Full Text] [Related]  

  • 24. [The role of Helicobacter pilori: reasons to believe it].
    Amouretti M
    Rev Prat; 1990 Feb; 40(4):339-40. PubMed ID: 2305196
    [No Abstract]   [Full Text] [Related]  

  • 25. Guidelines for the treatment of Helicobacter pylori in the pediatric population.
    Robinson DM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1997 Oct; 31(10):1247-9. PubMed ID: 9337451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori gastritis and non-ulcer dyspepsia in childhood. Efficacy of one-week triple antimicrobial therapy in eradicating the organism.
    Cucchiara S; Salvia G; Az-Zeqeh N; D'Armiento FD; De Petra MR; Rapagiolo S; Campanozzi A; Emiliano M
    Ital J Gastroenterol; 1996; 28(8):430-5. PubMed ID: 9032584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenicity of Campylobacter pylori--a causative factor in gastritis?
    McNulty CA
    Scand J Gastroenterol Suppl; 1989; 160():3-6. PubMed ID: 2683021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy of H. pylori infection.
    Bazzoli F; Pozzato P
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():39-46. PubMed ID: 9440054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Meta-analysis of determining the pathogen eradicating efficacy of various therapeutic regimens in Helicobacter pylori infection].
    Dobrucali A; Canbakan B; Canbakan M; Bagatur N; Uzunismail H; Eralp Y; Akün E; Göksel S; Yurdakul I; Oktay E
    Wien Med Wochenschr; 1998; 148(20):464-8. PubMed ID: 10025050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modern gastritis therapy. New pathogenetic concepts. Significance of Campylobacter pylori. Use of bismuth compounds. Report of the 16th meeting of the Bayern Society of Gastroenterology. Bad Dürkheim, 21-22 October 1988].
    Fortschr Med Suppl; 1989; 55():1-15. PubMed ID: 2917722
    [No Abstract]   [Full Text] [Related]  

  • 31. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
    McNulty CA
    Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection.
    McNulty CA
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):96B-100B. PubMed ID: 2663605
    [No Abstract]   [Full Text] [Related]  

  • 33. Campylobacter pylori--therapy review.
    Axon AT
    Scand J Gastroenterol Suppl; 1989; 160():35-8. PubMed ID: 2683022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Helicobacter pylori in peptic ulcer disease.
    O'Connor HJ
    Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Helicobacter and peptic ulcer: history, diagnosis and therapy--when, in whom and how?].
    Beglinger C
    Schweiz Med Wochenschr; 1994 Mar; 124(10):426-8. PubMed ID: 8153602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Campylobacter pylori-associated chronic gastritis: a new entity in gastroduodenal diseases?].
    Börsch G; Wegener M
    Leber Magen Darm; 1988 Feb; 18(1):9-16. PubMed ID: 3280934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimicrobial drugs in the treatment of stomach and duodenal diseases associated with Campylobacter pylori].
    Perederiĭ VG; Rozhavin MA
    Klin Med (Mosk); 1989 Jan; 67(1):44-8. PubMed ID: 2654463
    [No Abstract]   [Full Text] [Related]  

  • 40. [Campylobacter pylori: cause of gastritis and ulcer disease?].
    Gebbers JO; Altermatt HJ; Altorfer J
    Schweiz Med Wochenschr; 1988 Apr; 118(16):577-83. PubMed ID: 3289114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.